Clinical Trial: Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy

U.S., June 4 -- ClinicalTrials.gov registry received information related to the study (NCT07624903) titled 'Letrozole Versus Methotrexate for Management of Undisturbed Ectopic Pregnancy' on May 23.

Brief Summary: The aim of work is to study the effectiveness of letrozole in treatment of early undisturbed ectopic pregnancy in comparison with Methotrexate.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Ectopic Pregnancy

Intervention: DRUG: Methotrexate (drug)

Methotrexate is a folic acid antagonist that inhibits the enzyme dihydrofolate reductase, which converts folic acid to tetrahydrofolate, a cofactor needed in DNA and RNA synthesis

DRUG: Letrozole 2.5Mg Tab

Aromatase inhibitors has been shown toSuccessfully b...